ICP-330

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameICP-330
Drug Alias NameICP-330
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsPsoriasisLupus Erythematosus, SystemicInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeijing Innocare Pharma Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Innocare Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisLupus Erythematosus, SystemicInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A